BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 36201401)

  • 1. Incidence of Monkeypox Among Unvaccinated Persons Compared with Persons Receiving ≥1 JYNNEOS Vaccine Dose - 32 U.S. Jurisdictions, July 31-September 3, 2022.
    Payne AB; Ray LC; Kugeler KJ; Fothergill A; White EB; Canning M; Farrar JL; Feldstein LR; Gundlapalli AV; Houck K; Kriss JL; Lewis NM; Sims E; Smith DK; Spicknall IH; Nakazawa Y; Damon IK; Cohn AC; Payne DC
    MMWR Morb Mortal Wkly Rep; 2022 Oct; 71(40):1278-1282. PubMed ID: 36201401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced Risk for Mpox After Receipt of 1 or 2 Doses of JYNNEOS Vaccine Compared with Risk Among Unvaccinated Persons - 43 U.S. Jurisdictions, July 31-October 1, 2022.
    Payne AB; Ray LC; Cole MM; Canning M; Houck K; Shah HJ; Farrar JL; Lewis NM; Fothergill A; White EB; Feldstein LR; Roper LE; Lee F; Kriss JL; Sims E; Spicknall IH; Nakazawa Y; Gundlapalli AV; Shimabukuro T; Cohen AL; Honein MA; Mermin J; Payne DC
    MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(49):1560-1564. PubMed ID: 36480479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receipt of First and Second Doses of JYNNEOS Vaccine for Prevention of Monkeypox - United States, May 22-October 10, 2022.
    Kriss JL; Boersma PM; Martin E; Reed K; Adjemian J; Smith N; Carter RJ; Tan KR; Srinivasan A; McGarvey S; McGehee J; Henderson D; Aleshire N; Gundlapalli AV
    MMWR Morb Mortal Wkly Rep; 2022 Oct; 71(43):1374-1378. PubMed ID: 36301741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estimated Effectiveness of JYNNEOS Vaccine in Preventing Mpox: A Multijurisdictional Case-Control Study - United States, August 19, 2022-March 31, 2023.
    Dalton AF; Diallo AO; Chard AN; Moulia DL; Deputy NP; Fothergill A; Kracalik I; Wegner CW; Markus TM; Pathela P; Still WL; Hawkins S; Mangla AT; Ravi N; Licherdell E; Britton A; Lynfield R; Sutton M; Hansen AP; Betancourt GS; Rowlands JV; Chai SJ; Fisher R; Danza P; Farley M; Zipprich J; Prahl G; Wendel KA; Niccolai L; Castilho JL; Payne DC; Cohn AC; Feldstein LR; ;
    MMWR Morb Mortal Wkly Rep; 2023 May; 72(20):553-558. PubMed ID: 37200229
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demographic and Clinical Characteristics of Mpox in Persons Who Had Previously Received 1 Dose of JYNNEOS Vaccine and in Unvaccinated Persons - 29 U.S. Jurisdictions, May 22-September 3, 2022.
    Farrar JL; Lewis NM; Houck K; Canning M; Fothergill A; Payne AB; Cohen AL; Vance J; Brassil B; Youngkin E; Glenn B; Mangla A; Kupferman N; Saunders K; Meza C; Nims D; Soliva S; Blouse B; Henderson T; Banerjee E; White B; Birn R; Stadelman AM; Abrego M; McLafferty M; Eberhart MG; Pietrowski M; De León SM; Creegan E; Diedhiou A; Wiedeman C; Murray-Thompson J; McCarty E; Marcinkevage J; Kocharian A; Torrone EA; Ray LC; Payne DC;
    MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(5152):1610-1615. PubMed ID: 36580416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of JYNNEOS Vaccine Against Diagnosed Mpox Infection - New York, 2022.
    Rosenberg ES; Dorabawila V; Hart-Malloy R; Anderson BJ; Miranda W; O'Donnell T; Gonzalez CJ; Abrego M; DelBarba C; Tice CJ; McGarry C; Mitchell EC; Boulais M; Backenson B; Kharfen M; McDonald J; Bauer UE
    MMWR Morb Mortal Wkly Rep; 2023 May; 72(20):559-563. PubMed ID: 37339074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. JYNNEOS Vaccination Coverage Among Persons at Risk for Mpox - United States, May 22, 2022-January 31, 2023.
    Owens LE; Currie DW; Kramarow EA; Siddique S; Swanson M; Carter RJ; Kriss JL; Boersma PM; Lee FC; Spicknall I; Hurley E; Zlotorzynska M; Gundlapalli AV
    MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(13):342-347. PubMed ID: 36995962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety Monitoring of JYNNEOS Vaccine During the 2022 Mpox Outbreak - United States, May 22-October 21, 2022.
    Duffy J; Marquez P; Moro P; Weintraub E; Yu Y; Boersma P; Donahue JG; Glanz JM; Goddard K; Hambidge SJ; Lewin B; Lewis N; Rouse D; Shimabukuro T
    MMWR Morb Mortal Wkly Rep; 2022 Dec; 71(49):1555-1559. PubMed ID: 36480476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress Toward Equitable Mpox Vaccination Coverage: A Shortfall Analysis - United States, May 2022-April 2023.
    Kota KK; Chesson H; Hong J; Zelaya C; Spicknall IH; Riser AP; Hurley E; Currie DW; Lash RR; Carnes N; Concepción-Acevedo J; Ellington S; Belay ED; Mermin J
    MMWR Morb Mortal Wkly Rep; 2023 Jun; 72(23):627-632. PubMed ID: 37289660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological responses to the MVA-based JYNNEOS monkeypox vaccine in a cohort of participants from the Democratic Republic of Congo.
    Priyamvada L; Carson WC; Ortega E; Navarra T; Tran S; Smith TG; Pukuta E; Muyamuna E; Kabamba J; Nguete BU; Likafi T; Kokola G; Lushima RS; Tamfum JM; Okitolonda EW; Kaba DK; Monroe BP; McCollum AM; Petersen BW; Satheshkumar PS; Townsend MB
    Vaccine; 2022 Nov; 40(50):7321-7327. PubMed ID: 36344361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiologic Features of the Monkeypox Outbreak and the Public Health Response - United States, May 17-October 6, 2022.
    Kava CM; Rohraff DM; Wallace B; Mendoza-Alonzo JL; Currie DW; Munsey AE; Roth NM; Bryant-Genevier J; Kennedy JL; Weller DL; Christie A; McQuiston JH; Hicks P; Strid P; Sims E; Negron ME; Iqbal K; Ellington S; Smith DK
    MMWR Morb Mortal Wkly Rep; 2022 Nov; 71(45):1449-1456. PubMed ID: 36355615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orthopoxvirus Testing Challenges for Persons in Populations at Low Risk or Without Known Epidemiologic Link to Monkeypox - United States, 2022.
    Minhaj FS; Petras JK; Brown JA; Mangla AT; Russo K; Willut C; Lee M; Beverley J; Harold R; Milroy L; Pope B; Gould E; Beeler C; Schneider J; Mostafa HH; Godfred-Cato S; Click ES; Borah BF; Galang RR; Cash-Goldwasser S; Wong JM; McCormick DW; Yu PA; Shelus V; Carpenter A; Schatzman S; Lowe D; Townsend MB; Davidson W; Wynn NT; Satheshkumar PS; O'Connor SM; O'Laughlin K; Rao AK; McCollum AM; Negrón ME; Hutson CL; Salzer JS; ;
    MMWR Morb Mortal Wkly Rep; 2022 Sep; 71(36):1155-1158. PubMed ID: 36074752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccine Effectiveness of JYNNEOS against Mpox Disease in the United States.
    Deputy NP; Deckert J; Chard AN; Sandberg N; Moulia DL; Barkley E; Dalton AF; Sweet C; Cohn AC; Little DR; Cohen AL; Sandmann D; Payne DC; Gerhart JL; Feldstein LR
    N Engl J Med; 2023 Jun; 388(26):2434-2443. PubMed ID: 37199451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Health Equity Approach for Implementation of JYNNEOS Vaccination at Large, Community-Based LGBTQIA+ Events - Georgia, August 27-September 5, 2022.
    Millman AJ; Denson DJ; Allen ML; Malone JA; Daskalakis DC; Durrence D; Rustin RC; Toomey KE;
    MMWR Morb Mortal Wkly Rep; 2022 Oct; 71(43):1382-1883. PubMed ID: 36301799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monkeypox Virus Infections After 2 Preexposure Doses of JYNNEOS Vaccine - United States, May 2022-May 2024.
    Guagliardo SAJ; Kracalik I; Carter RJ; Braden C; Free R; Hamal M; Tuttle A; McCollum AM; Rao AK
    MMWR Morb Mortal Wkly Rep; 2024 May; 73(20):460-466. PubMed ID: 38781111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of JYNNEOS (Smallpox and Monkeypox Vaccine, Live, Nonreplicating) for Preexposure Vaccination of Persons at Risk for Occupational Exposure to Orthopoxviruses: Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.
    Rao AK; Petersen BW; Whitehill F; Razeq JH; Isaacs SN; Merchlinsky MJ; Campos-Outcalt D; Morgan RL; Damon I; Sánchez PJ; Bell BP
    MMWR Morb Mortal Wkly Rep; 2022 Jun; 71(22):734-742. PubMed ID: 35653347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demographic Disparities in Mpox Vaccination Series Completion, by Route of Vaccine Administration - California, August 9, 2022-March 31, 2023.
    Salih T; Vance J; Quint J; Meza B; McNitt L; Lincoln WU; Schechter R
    MMWR Morb Mortal Wkly Rep; 2023 Jul; 72(30):827-832. PubMed ID: 37498796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interim Guidance for Prevention and Treatment of Monkeypox in Persons with HIV Infection - United States, August 2022.
    O'Shea J; Filardo TD; Morris SB; Weiser J; Petersen B; Brooks JT
    MMWR Morb Mortal Wkly Rep; 2022 Aug; 71(32):1023-1028. PubMed ID: 35951495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiologic and Clinical Characteristics of Monkeypox Cases - United States, May 17-July 22, 2022.
    Philpott D; Hughes CM; Alroy KA; Kerins JL; Pavlick J; Asbel L; Crawley A; Newman AP; Spencer H; Feldpausch A; Cogswell K; Davis KR; Chen J; Henderson T; Murphy K; Barnes M; Hopkins B; Fill MA; Mangla AT; Perella D; Barnes A; Hughes S; Griffith J; Berns AL; Milroy L; Blake H; Sievers MM; Marzan-Rodriguez M; Tori M; Black SR; Kopping E; Ruberto I; Maxted A; Sharma A; Tarter K; Jones SA; White B; Chatelain R; Russo M; Gillani S; Bornstein E; White SL; Johnson SA; Ortega E; Saathoff-Huber L; Syed A; Wills A; Anderson BJ; Oster AM; Christie A; McQuiston J; McCollum AM; Rao AK; Negrón ME;
    MMWR Morb Mortal Wkly Rep; 2022 Aug; 71(32):1018-1022. PubMed ID: 35951487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial and Ethnic Disparities in Mpox Cases and Vaccination Among Adult Males - United States, May-December 2022.
    Kota KK; Hong J; Zelaya C; Riser AP; Rodriguez A; Weller DL; Spicknall IH; Kriss JL; Lee F; Boersma P; Hurley E; Hicks P; Wilkins C; Chesson H; Concepción-Acevedo J; Ellington S; Belay E; Mermin J
    MMWR Morb Mortal Wkly Rep; 2023 Apr; 72(15):398-403. PubMed ID: 37053122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.